Bausch Health [BHC] vs Zoetis [ZTS] Detailed Stock Comparison

Bausch Health Companies Inc.

NYSE
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Bausch Health Companies Inc. wins in 11 metrics, Zoetis Inc. wins in 9 metrics, with 0 ties. Bausch Health Companies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bausch Health Companies Inc. Zoetis Inc. Better
P/E Ratio (TTM) 13.19 19.58 Bausch Health Companies Inc.
Price-to-Book Ratio 5.58 15.04 Bausch Health Companies Inc.
Debt-to-Equity Ratio 5,591.25 279.59 Zoetis Inc.
PEG Ratio -0.06 2.81 Zoetis Inc.
EV/EBITDA 6.69 13.96 Bausch Health Companies Inc.
Profit Margin (TTM) 1.53% 28.24% Zoetis Inc.
Operating Margin (TTM) 25.79% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 25.79% 34.69% Zoetis Inc.
Return on Equity 436.36% 65.99% Bausch Health Companies Inc.
Return on Assets (TTM) 5.18% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $993.00M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return -15.38% -51.58% Bausch Health Companies Inc.
Price-to-Sales Ratio (TTM) 0.20 5.26 Bausch Health Companies Inc.
Enterprise Value $22.75B $56.75B Zoetis Inc.
EV/Revenue Ratio 2.22 6.00 Bausch Health Companies Inc.
Gross Profit Margin (TTM) 71.46% 70.17% Bausch Health Companies Inc.
Revenue per Share (TTM) $28 $21 Bausch Health Companies Inc.
Earnings per Share (Diluted) $0.42 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.40 0.97 Bausch Health Companies Inc.
Short % of Float 2.00% 4.06% Bausch Health Companies Inc.

Bausch Health Companies Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

BHC
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch Health Companies Inc.-1.38%-2.35%-7.93%-0.80%-27.79%-30.79%
Zoetis Inc.1.51%0.16%3.42%-31.08%-32.94%-36.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch Health Companies Inc.-15.38%-31.16%-82.74%-77.04%-89.99%-77.64%
Zoetis Inc.-51.58%-53.40%-57.08%71.34%156.59%156.59%

Performance & Financial Health Analysis: Bausch Health Companies Inc. vs Zoetis Inc.

MetricBHCZTS
Market Information
Market Cap i$2.10B$49.75B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,154,6892,727,710
90 Day Avg. Volume i1,376,9663,835,940
Last Close$4.99$167.10
52 Week Range$4.93 - $8.69$139.70 - $200.33
% from 52W High-42.58%-16.59%
All-Time High$263.81 (Aug 03, 2015)$249.27 (Dec 27, 2021)
% from All-Time High-98.11%-32.96%
Growth Metrics
Quarterly Revenue Growth0.09%0.03%
Quarterly Earnings GrowthN/A0.04%
Financial Health
Profit Margin (TTM) i0.02%0.28%
Operating Margin (TTM) i0.26%0.35%
Return on Equity (TTM) i4.36%0.66%
Debt to Equity (MRQ) i5,591.25279.59
Cash & Liquidity
Book Value per Share (MRQ)$-1.50$7.84
Cash per Share (MRQ)$3.53$5.48
Operating Cash Flow (TTM) i$1.40B$2.90B
Levered Free Cash Flow (TTM) i$1.09B$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend i$0.00$2.03

Valuation & Enterprise Metrics Analysis: Bausch Health Companies Inc. vs Zoetis Inc.

MetricBHC (Apr 26, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i13.1919.58
Forward P/E i1.3715.61
PEG Ratio i-0.062.81
Price to Sales (TTM) i0.205.26
Price to Book (MRQ) i5.5815.04
Market Capitalization
Market Capitalization i$2.10B$49.75B
Enterprise Value i$22.75B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i2.226.00
Enterprise to EBITDA i6.6913.96
Risk & Other Metrics
Beta i0.400.97
Book Value per Share (MRQ) i$-1.50$7.84

Financial Statements Comparison: Bausch Health Companies Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBHC (2025)ZTS (2025)
Revenue/Sales i10.27B9.47B
Cost of Goods Sold i3.01B2.67B
COGS % of Revenue i29.3%28.2%
Gross Profit i7.25B6.80B
Gross Margin i70.7%71.8%
Research & Development i629.00M698.00M
Operating Income (EBIT) i2.19B3.60B
Operating Margin i21.3%38.0%
EBITDA i3.44B4.17B
EBITDA Margin i33.5%44.1%
Pre-Tax Income i367.00M3.36B
Pre-Tax Income % of Revenue i3.6%35.5%
Income Tax i247.00M687.00M
Income Tax % of Revenue i2.4%7.3%
Net Income (Profit) i120.00M2.67B
Profit Margin i1.2%28.2%

Balance Sheet & Liquidity Metrics

MetricBHC (2025)ZTS (2025)
Cash & Equivalents i1.31B2.31B
Total Current Assets i6.16B6.77B
Total Current Assets % of Revenue i60.0%71.5%
Total Current Liabilities i4.18B2.24B
Total Current Liabilities % of Revenue i40.7%23.6%
Long-Term Debt i20.62B9.24B
Long-Term Debt % of Revenue i200.8%97.6%
Total Shareholders Equity i377.00M3.33B
Retained Earnings i-9.67B13.74B
Retained Earnings % of Revenue i-94.2%145.2%
Property, Plant & Equipment i112.00M288.00M

Cash Flow Statement Comparison

MetricBHC (2025)ZTS (2025)
Operating Cash Flow i1.36B2.78B
Operating Cash Flow % of Revenue i13.3%29.3%
Capital Expenditures i-397.00MN/A
Free Cash Flow i993.00M2.28B
FCF Margin i9.7%24.1%
Debt Repayment i-11.19B-1.35B
Common Stock Repurchase iN/A-3.24B

Short Interest & Institutional Ownership Analysis

MetricBHCZTS
Shares Short i5.99M15.12M
Short Ratio i2.673.60
Short % of Float i2.00%4.06%
Shares Outstanding i370.53M424.93M
Float Shares i258.52M421.29M
% Held by Insiders i30.41%0.15%
% Held by Institutions i65.20%101.50%
% Held by Public i4.39%-1.65%

Dividend Analysis & Yield Comparison: Bausch Health Companies Inc. vs Zoetis Inc.

MetricBHCZTS
Last 12-Month Dividend i$0.00$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend i$0.00$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends i$0.00$5.39
Ex-Dividend DateN/AJan 20, 2026